Tarik Benidir, Zaeem Lone, Andrew Wood, Nour Abdallah, Rebecca Campbell, Petar Bajic, Andrei Purysko, Jane K Nguyen, Jihad Kaouk, Georges-Pascal Haber, Mohamed Eltemamy, Robert Stein, Samuel Haywood, Eric A Klein, Nima Almassi, Steven C Campbell, Robert Abouassaly, Christopher J Weight
OBJECTIVE: To assess how IsoPSA, a structure-based serum assay which has been prospectively validated in detecting clinically significant prostate cancer (csPCa), can help the biopsy decision process when combined with the Prostate Imaging Reporting and Data Systems (PI-RADS). MATERIALS AND METHODS: This was a single-center retrospective review of prospectively collected data on patients receiving IsoPSA testing for elevated PSA (>4.0ng/mL). Patients were included if they had received an IsoPSA test and prostate MRI within one year of IsoPSA testing, and subsequently underwent prostate biopsy...
March 23, 2023: Urology